Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Hereditary hemochromatosis gene discovered

Aug. 16, 1996

Aptamer-based PCR system to be codeveloped by NeXstar and Roche

Aug. 16, 1996

Neurocrine Biosciences receives SBIR grant for combinatorial chemistry technology

Aug. 16, 1996

European patent broadly protects Pharming's transgenic cattle generation technology

Aug. 9, 1996

Sequana to acquire NemaPharm

Aug. 9, 1996

Guilford obtains exclusive rights to drug delivery technology

Aug. 9, 1996

Collaboration on production/delivery system of microbial antigens announced

Aug. 9, 1996

Merck discontinues screening agreement with Martek

Aug. 9, 1996

University of Colorado's ribozyme technology protected by Japanese patent

Aug. 9, 1996

Genomic map development accord signed

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...